# Trial Investigating the Efficacy and Safety of SCH 900435 (Org 25935) in Relapse Prevention in Participants With Alcohol Dependence (P05718)

> **NCT00764660** · PHASE2 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 141 (actual)

## Conditions studied

- Alcoholism

## Interventions

- **DRUG:** SCH 900435
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00764660
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02-13
- **Primary completion:** 2010-05-28
- **Final completion:** 2010-07-08
- **Target enrollment:** 141 (ACTUAL)
- **Why stopped:** Based on the outcome of a planned interim analysis, the study was stopped early due to futility.
- **Last updated:** 2018-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00764660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00764660, "Trial Investigating the Efficacy and Safety of SCH 900435 (Org 25935) in Relapse Prevention in Participants With Alcohol Dependence (P05718)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00764660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*